000			01723 a2200445 4500
005			20250518081351.0
264		0	_c20210503
008			202105s 0 0 eng d
022			_a1522-9653
024	7		_a10.1016/j.joca.2020.01.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aKloppenburg, M
245	0	0	_aOsteoarthritis year in review 2019: epidemiology and therapy. _h[electronic resource]
260			_bOsteoarthritis and cartilage _c03 2020
300			_a242-248 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAcetaminophen _xtherapeutic use
650	0	4	_aAnalgesics, Non-Narcotic _xtherapeutic use
650	0	4	_aAnalgesics, Opioid _xtherapeutic use
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aArthroplasty, Replacement
650	0	4	_aBiological Products _xtherapeutic use
650	0	4	_aCapsaicin _xtherapeutic use
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunoglobulins _xtherapeutic use
650	0	4	_aInjections, Intra-Articular
650	0	4	_aInjections, Intramuscular
650	0	4	_aMortality
650	0	4	_aOsteoarthritis _xepidemiology
650	0	4	_aPain Management
650	0	4	_aRisk Assessment
650	0	4	_aSensory System Agents _xtherapeutic use
650	0	4	_aTramadol _xtherapeutic use
650	0	4	_aTumor Necrosis Factor Inhibitors _xtherapeutic use
700	1		_aBerenbaum, F
773	0		_tOsteoarthritis and cartilage _gvol. 28 _gno. 3 _gp. 242-248
856	4	0	_uhttps://doi.org/10.1016/j.joca.2020.01.002 _zAvailable from publisher's website
999			_c30526115 _d30526115